share_log

三葉草生物-B：截至2023年12月31日止月份股份發行人的證券變動月報表

CLOVER BIO-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended December 31, 2023

香港交易所 ·  Jan 2 22:03
Summary by Moomoo AI
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有712,000股份期權被行使，並因此發行了相同數量的新股份。本月內因行使期權所得資金總額為5,696港元。該報告亦確認了所有相關的上市規則要求均已遵守。
三葉草生物製藥有限公司（「三叶草生物-B」）於2024年1月3日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底及本月底結存均為2,000,000,000股，每股面值0.0001美元，總額200,000美元。在股份期權方面，根據首次公開發售前後的購股權計劃，本月內有712,000股份期權被行使，並因此發行了相同數量的新股份。本月內因行使期權所得資金總額為5,696港元。該報告亦確認了所有相關的上市規則要求均已遵守。
Clover Biopharmaceuticals Limited (“Clover Bio-B”) filed with Hong Kong Trading and Clearing Limited on 3 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In terms of stock options, 712,000 share options were exercised during the month under the IPO and as a result the same number of new shares were issued. The total amount of capital received from the exercise of options during the month was HK$5,696. The report also confirms that all relevant listing rules requirements have been complied with.
Clover Biopharmaceuticals Limited (“Clover Bio-B”) filed with Hong Kong Trading and Clearing Limited on 3 January 2024 its Statement of Monthly Changes in Securities for the year ended 31 December 2023. The report shows that the company's regulated/registered share capital remained unchanged, with 2,000,000,000 shares outstanding at the end of last month and at the end of this month, with a face value of $0.0001 per share for a total amount of $200,000. In terms of stock options, 712,000 share options were exercised during the month under the IPO and as a result the same number of new shares were issued. The total amount of capital received from the exercise of options during the month was HK$5,696. The report also confirms that all relevant listing rules requirements have been complied with.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more